MIRAMAR, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing ...

HCW Biologics Inc. announced the approval of a reverse stock split following a Special Meeting of Stockholders on March 31, 2025. The pharmaceutical company, currently trading at $0.28 with a market ...

19:50 EDT Hcw Biologics (HCWB) Inc trading halted, news pending Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for ...

In Europe, the introduction of HBV vaccination has markedly reduced the incidence of acute HBV, and before the introduction of HBV vaccine, healthcare workers (HCW) were at considerable risk of ...